Finance

Lists
CCNE:NASDAQ
CNB Financial Corp
$34.15
+0.09%
(+0.030) 1D
Oct 19, 11:29:19 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCNE...
Open
$34.09
High
$34.38
Low
$33.95
Mkt. cap
1.01B
Avg. vol.
135.52K
Volume
13.01K
Dividend
2.23%
Quarterly dividend
$0.19
Ex-dividend date
Sep 1, 2026
P/E ratio
11.00
52-wk high
$36.17
52-wk low
$23.37
EPS
$3.10
Beta
0.62
Shares outstanding
29.62M
No. of employees
934
Open
$34.09
High
$34.38
Low
$33.95
Mkt. cap
1.01B
Avg. vol.
135.52K
Volume
13.01K
Dividend
2.23%
Quarterly dividend
$0.19
Ex-dividend date
Sep 1, 2026
P/E ratio
11.00
52-wk high
$36.17
52-wk low
$23.37
EPS
$3.10
Beta
0.62
Shares outstanding
29.62M
No. of employees
934
News stories
From web sources and news partners
About CNB Financial Corp
CEO-
Employees934
Founded1865
Headquarters-
SectorBank
Websitecnbbank.bank
Analyst ratings
Based on 4 analysts giving stock ratings to CCNE in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CCNE in the last 3 months.
Highest
Current $34.15
$39.00 (+14.20%)
Average
$37.50 (+9.81%)
Lowest
$36.00 (+5.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Kroll
Piper Sandler
Buy
Initiated
$38.00
+11.3%
09/24/2026
Daniel Tamayo
Raymond James
Buy
Initiated
$39.00
+14.2%
08/27/2026
Jake Civiello
D.A. Davidson
Hold
Maintained
$36.00
+5.4%
07/27/2026
Tim Switzer
KBW
Hold
Reiterated
$37.00
+8.3%
07/24/2026
Parker Wittmann
D.A. Davidson
Hold
Initiated
-
-
05/14/2026
Matthew Breese
Stephens
Buy
Maintained
$35.00
+2.5%
02/11/2026
Next call in 10 days
Thu, Oct 29, 10:00 PM
Fiscal period
Q3 2026
- / $0.88
Revenue / Est. (USD)
- / 76.80M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
59.24M
101.86M
82.32M
85.87M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.04M
41.22M
39.17M
37.45M
Operating expense
44.28M
50.05M
47.38M
48.67M
Total operating expenses
44.28M
50.05M
47.38M
48.67M
Operating income
14.96M
51.81M
34.95M
37.20M
Other non operating income
-1.72M
-2.24M
-1.81M
-2.04M
EBT including unusual items
9.08M
41.79M
33.14M
35.16M
EBT excluding unusual items
13.24M
49.57M
33.14M
35.16M
Income tax expense
2.04M
8.14M
6.10M
6.86M
Effective tax rate
22.43%
19.48%
18.41%
19.50%
Other operating expenses
8.24M
8.83M
8.20M
11.22M
Net income
7.04M
33.65M
27.04M
28.30M
Net profit margin
11.89%
33.04%
32.84%
32.96%
Earnings per share
0.82
0.87
0.88
0.91
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
83.00K
990.00K
-340.00K
-63.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps